-
1
-
-
1942468646
-
Local application of rapamycin inhibits neointimal hyperplasia in experimental vein grafts
-
Schachner T., Zou Y., Oberhuber A., et al. Local application of rapamycin inhibits neointimal hyperplasia in experimental vein grafts. Ann Thorac Surg 77 (2004) 1580-1585
-
(2004)
Ann Thorac Surg
, vol.77
, pp. 1580-1585
-
-
Schachner, T.1
Zou, Y.2
Oberhuber, A.3
-
2
-
-
38949178323
-
Everolimus reduces intimal proliferation in an ex vivo model of vascular injury
-
Cornelissen J., Gandlau-White A., Southwood M., et al. Everolimus reduces intimal proliferation in an ex vivo model of vascular injury. J Heart Lung Transplant 25 suppl (2006) 107
-
(2006)
J Heart Lung Transplant
, vol.25
, Issue.SUPPL
, pp. 107
-
-
Cornelissen, J.1
Gandlau-White, A.2
Southwood, M.3
-
3
-
-
33947681290
-
Recommendations for the use of everolimus (Certican) in heart transplantation: results from the second German-Austrian Certican Consensus Conference
-
Rothenburger M., Zuckermann A., Bara C., et al. Recommendations for the use of everolimus (Certican) in heart transplantation: results from the second German-Austrian Certican Consensus Conference. J Heart Lung Transplant 26 (2007) 305-311
-
(2007)
J Heart Lung Transplant
, vol.26
, pp. 305-311
-
-
Rothenburger, M.1
Zuckermann, A.2
Bara, C.3
-
5
-
-
20844461132
-
Sirolimus in de novo heart transplant recipients reduces acute rejection and prevents coronary artery disease at 2 years-a randomized clinical trial
-
Keogh A., Richardson M., Ruygrok P., et al. Sirolimus in de novo heart transplant recipients reduces acute rejection and prevents coronary artery disease at 2 years-a randomized clinical trial. Circulation 110 (2004) 2694-2700
-
(2004)
Circulation
, vol.110
, pp. 2694-2700
-
-
Keogh, A.1
Richardson, M.2
Ruygrok, P.3
-
6
-
-
19244366021
-
Everolimus for the prevention of allograft rejection and vasculopathy in cardiac transplant recipients
-
Eisen H.J., Tuzcu E.M., Dorent R., et al. Everolimus for the prevention of allograft rejection and vasculopathy in cardiac transplant recipients. N Engl J Med 349 (2003) 847-858
-
(2003)
N Engl J Med
, vol.349
, pp. 847-858
-
-
Eisen, H.J.1
Tuzcu, E.M.2
Dorent, R.3
-
7
-
-
15044351065
-
Clinical experience with Certican (everolimus) in de novo heart transplant patients at the Deutsches Herzzentrum Berlin
-
Lehmkuhl H., and Hetzer R. Clinical experience with Certican (everolimus) in de novo heart transplant patients at the Deutsches Herzzentrum Berlin. J Heart Lung Transplant 24 suppl 4 (2005) 201-205
-
(2005)
J Heart Lung Transplant
, vol.24
, Issue.SUPPL. 4
, pp. 201-205
-
-
Lehmkuhl, H.1
Hetzer, R.2
-
8
-
-
15044345672
-
Clinical experience with Certican (everolimus) in maintenance heart transplant patients at the Medical University of Vienna
-
Zuckermann A. Clinical experience with Certican (everolimus) in maintenance heart transplant patients at the Medical University of Vienna. J Heart Lung Transplant 24 suppl 4 (2005) 206-209
-
(2005)
J Heart Lung Transplant
, vol.24
, Issue.SUPPL. 4
, pp. 206-209
-
-
Zuckermann, A.1
-
9
-
-
33646404334
-
Everolimus and reduced cyclosporine trough levels in maintenance heart transplant recipients
-
Schweiger M., Wasler A., Prenner G., et al. Everolimus and reduced cyclosporine trough levels in maintenance heart transplant recipients. Transplant Immunol 16 (2006) 46-51
-
(2006)
Transplant Immunol
, vol.16
, pp. 46-51
-
-
Schweiger, M.1
Wasler, A.2
Prenner, G.3
-
10
-
-
29544442185
-
Everolimus (Certican) in heart transplantation-optimizing renal function through minimizing cyclosporine exposure
-
Lehmkuhl H., Ross H., Eisen H., and Valantine H. Everolimus (Certican) in heart transplantation-optimizing renal function through minimizing cyclosporine exposure. Transplant Proc 37 (2005) 4145-4149
-
(2005)
Transplant Proc
, vol.37
, pp. 4145-4149
-
-
Lehmkuhl, H.1
Ross, H.2
Eisen, H.3
Valantine, H.4
-
11
-
-
33947699939
-
Neoral and Certican can safely be combined in stable cardiac transplant recipients: six week interim analysis of a Canadian pilot study
-
Ross H., Burton J., Pflugfelder P., Dorent R., and Loertscher R. Neoral and Certican can safely be combined in stable cardiac transplant recipients: six week interim analysis of a Canadian pilot study. Transplant Int 18 suppl 1 (2005) PO097
-
(2005)
Transplant Int
, vol.18
, Issue.SUPPL. 1
-
-
Ross, H.1
Burton, J.2
Pflugfelder, P.3
Dorent, R.4
Loertscher, R.5
-
12
-
-
38949177650
-
-
Presented at the annual meeting of the International Society for Heart and Lung Transplantation (ISHLT), San Francisco, CA, April
-
Lehmkuhl H., Livi U., Boissonat P., et al. Everolimus with reduced cyclosporine exposure vs. MMF and conventional cyclosporine: 6 month data from a 12 month study in de novo heart transplant recipients (2007) Presented at the annual meeting of the International Society for Heart and Lung Transplantation (ISHLT), San Francisco, CA, April
-
(2007)
Everolimus with reduced cyclosporine exposure vs. MMF and conventional cyclosporine: 6 month data from a 12 month study in de novo heart transplant recipients
-
-
Lehmkuhl, H.1
Livi, U.2
Boissonat, P.3
-
13
-
-
37149054281
-
The role of everolimus in the improvement of renal function in heart transplant recipients
-
Fuchs U., Zittermann A., Tenderich G., et al. The role of everolimus in the improvement of renal function in heart transplant recipients. Transplant Int 18 suppl 1 (2005) PO094
-
(2005)
Transplant Int
, vol.18
, Issue.SUPPL. 1
-
-
Fuchs, U.1
Zittermann, A.2
Tenderich, G.3
-
14
-
-
0042360213
-
Chronic renal failure after transplantation of a nonrenal organ
-
Ojo A.O., Held P.J., Pork F.K., et al. Chronic renal failure after transplantation of a nonrenal organ. N Engl J Med 349 (2003) 931-940
-
(2003)
N Engl J Med
, vol.349
, pp. 931-940
-
-
Ojo, A.O.1
Held, P.J.2
Pork, F.K.3
-
15
-
-
0021280574
-
Cyclosporine-associated chronic nephropathy
-
Myers B.D., Ross J., Newton L., et al. Cyclosporine-associated chronic nephropathy. N Engl J Med 311 (1984) 699-705
-
(1984)
N Engl J Med
, vol.311
, pp. 699-705
-
-
Myers, B.D.1
Ross, J.2
Newton, L.3
-
16
-
-
0026212083
-
Cyclosporine-induced chronic nephropathy: an obliterative microvascular renal injury
-
Myers B.D., and Newton L. Cyclosporine-induced chronic nephropathy: an obliterative microvascular renal injury. J Am Soc Nephrol 2 suppl (1991) S45-S52
-
(1991)
J Am Soc Nephrol
, vol.2
, Issue.SUPPL
-
-
Myers, B.D.1
Newton, L.2
-
17
-
-
38949086077
-
-
Presented at the ACR/ARHP annual scientific meeting, San Francisco, October
-
Bruyn G.A.W., Tate G., Caeiro F., et al. Everolimus in patients with rheumatoid arthritis receiving methotrexate: a 3-month, double-blind, randomized, placebo-controlled, parallel-group, proof-of-concept study (2004) Presented at the ACR/ARHP annual scientific meeting, San Francisco, October
-
(2004)
Everolimus in patients with rheumatoid arthritis receiving methotrexate: a 3-month, double-blind, randomized, placebo-controlled, parallel-group, proof-of-concept study
-
-
Bruyn, G.A.W.1
Tate, G.2
Caeiro, F.3
-
18
-
-
0038817791
-
Drug monitoring of sirolimus and everolimus
-
Armstrong V.W., and Streit F. Drug monitoring of sirolimus and everolimus. Lab Medizin 27 (2003) 222-227
-
(2003)
Lab Medizin
, vol.27
, pp. 222-227
-
-
Armstrong, V.W.1
Streit, F.2
-
19
-
-
0036253476
-
Sirolimus allows renal recovery in lung and heart transplant recipients with chronic renal impairment
-
Snell G.I., Levvey B.J., Chin W., et al. Sirolimus allows renal recovery in lung and heart transplant recipients with chronic renal impairment. J Heart Lung Transplant 21 (2002) 540-546
-
(2002)
J Heart Lung Transplant
, vol.21
, pp. 540-546
-
-
Snell, G.I.1
Levvey, B.J.2
Chin, W.3
-
20
-
-
21244454092
-
Initial experience with sirolimus and mycophenolate mofetil for renal rescue from cyclosporine nephrotoxicity after heart transplantation
-
Lyster H., Panicker G., Leaver N., and Banner N.R. Initial experience with sirolimus and mycophenolate mofetil for renal rescue from cyclosporine nephrotoxicity after heart transplantation. Transplant Proc 36 (2004) 3167-3170
-
(2004)
Transplant Proc
, vol.36
, pp. 3167-3170
-
-
Lyster, H.1
Panicker, G.2
Leaver, N.3
Banner, N.R.4
-
21
-
-
38949162105
-
Calcineurin inhibitor-free immunosuppression using everolimus in maintenance heart transplant recipients-9 months follow-up
-
Rothenburger M., Stypmann J., Loeher A., et al. Calcineurin inhibitor-free immunosuppression using everolimus in maintenance heart transplant recipients-9 months follow-up. Transplantation 82 suppl 2 (2006) 553
-
(2006)
Transplantation
, vol.82
, Issue.SUPPL. 2
, pp. 553
-
-
Rothenburger, M.1
Stypmann, J.2
Loeher, A.3
-
22
-
-
2642568316
-
Sirolimus and mycophenolate mofetil as calcineurin inhibitor-free immunosuppression in a cardiac transplant patient with chronic renal failure
-
Groetzner J., Kaczmarek I., Meiser B., et al. Sirolimus and mycophenolate mofetil as calcineurin inhibitor-free immunosuppression in a cardiac transplant patient with chronic renal failure. J Heart Lung Transplant 23 (2004) 770-773
-
(2004)
J Heart Lung Transplant
, vol.23
, pp. 770-773
-
-
Groetzner, J.1
Kaczmarek, I.2
Meiser, B.3
-
23
-
-
27844587421
-
Improvement of renal dysfunction by conversion from calcineurin inhibitors to sirolimus after heart transplantation
-
Hunt J., Lerman M., Magee M.J., et al. Improvement of renal dysfunction by conversion from calcineurin inhibitors to sirolimus after heart transplantation. J Heart Lung Transplant 24 (2005) 1863-1867
-
(2005)
J Heart Lung Transplant
, vol.24
, pp. 1863-1867
-
-
Hunt, J.1
Lerman, M.2
Magee, M.J.3
-
24
-
-
1542719221
-
Renal recovery after conversion to a calcineurin inhibitor-free immunosuppression in late cardiac transplant recipients
-
Groetzner J., Kaczmarek I., Landwehr P., et al. Renal recovery after conversion to a calcineurin inhibitor-free immunosuppression in late cardiac transplant recipients. Eur J Cardiothorac Surg 25 (2004) 333-341
-
(2004)
Eur J Cardiothorac Surg
, vol.25
, pp. 333-341
-
-
Groetzner, J.1
Kaczmarek, I.2
Landwehr, P.3
-
25
-
-
10744231167
-
Mycophenolate mofetil and sirolimus as calcineurin inhibitor-free immunosuppression for late cardiac-transplant recipients with chronic renal failure
-
Groetzner J., Meiser B., Landwehr P., et al. Mycophenolate mofetil and sirolimus as calcineurin inhibitor-free immunosuppression for late cardiac-transplant recipients with chronic renal failure. Transplantation 77 (2004) 568-574
-
(2004)
Transplantation
, vol.77
, pp. 568-574
-
-
Groetzner, J.1
Meiser, B.2
Landwehr, P.3
-
26
-
-
29144480970
-
Sirolimus in cardiac transplantation: use as a primary immunosuppressant in calcineurin inhibitor-induced nephrotoxicity
-
Kushwaha S.S., Khalpey Z., Frantz R.P., et al. Sirolimus in cardiac transplantation: use as a primary immunosuppressant in calcineurin inhibitor-induced nephrotoxicity. J Heart Lung Transplant 24 (2005) 2129-2136
-
(2005)
J Heart Lung Transplant
, vol.24
, pp. 2129-2136
-
-
Kushwaha, S.S.1
Khalpey, Z.2
Frantz, R.P.3
-
27
-
-
33645370770
-
Sirolimus in de novo heart transplant recipients with severe renal impairment
-
Vazquez de Prada J.A., Vilchez F.G., Cobo M., et al. Sirolimus in de novo heart transplant recipients with severe renal impairment. Transplant Int 19 (2006) 245-248
-
(2006)
Transplant Int
, vol.19
, pp. 245-248
-
-
Vazquez de Prada, J.A.1
Vilchez, F.G.2
Cobo, M.3
-
29
-
-
1342304173
-
Lymphomas after solid organ transplantation: a collaborative transplant study report
-
Opelz G., and Döhler B. Lymphomas after solid organ transplantation: a collaborative transplant study report. Am J Transplant 4 (2003) 222-230
-
(2003)
Am J Transplant
, vol.4
, pp. 222-230
-
-
Opelz, G.1
Döhler, B.2
-
30
-
-
0027501649
-
Incidence of non-Hodgkin lymphoma in kidney and heart transplant recipients
-
Opelz G., and Henderson R. Incidence of non-Hodgkin lymphoma in kidney and heart transplant recipients. Lancet 342 (1993) 1514-1516
-
(1993)
Lancet
, vol.342
, pp. 1514-1516
-
-
Opelz, G.1
Henderson, R.2
-
31
-
-
0032949981
-
Evaluation of individual and combined neurotoxicity of the immunosuppressants cyclosporine and sirolimus by in vitro multinuclear NMR spectroscopy
-
Serkova N., Litt L., James T.L., et al. Evaluation of individual and combined neurotoxicity of the immunosuppressants cyclosporine and sirolimus by in vitro multinuclear NMR spectroscopy. J Pharmacol Exp Ther 289 (1999) 800-806
-
(1999)
J Pharmacol Exp Ther
, vol.289
, pp. 800-806
-
-
Serkova, N.1
Litt, L.2
James, T.L.3
-
32
-
-
0034881393
-
Sirolimus, but not the structurally related RAD (everolimus), enhances the negative effects of cyclosporine on mitochondrial metabolism in the rat brain
-
Serkova N., Jacobsen W., Niemann C.U., et al. Sirolimus, but not the structurally related RAD (everolimus), enhances the negative effects of cyclosporine on mitochondrial metabolism in the rat brain. Br J Pharmacol 133 (2001) 875-885
-
(2001)
Br J Pharmacol
, vol.133
, pp. 875-885
-
-
Serkova, N.1
Jacobsen, W.2
Niemann, C.U.3
-
33
-
-
1542617940
-
Renal insufficiency and end-stage renal disease in the heart transplant population
-
Rubel J.R., Milford E.L., McKay D.B., and Jarcho J.A. Renal insufficiency and end-stage renal disease in the heart transplant population. J Heart Lung Transplant 23 (2004) 289-300
-
(2004)
J Heart Lung Transplant
, vol.23
, pp. 289-300
-
-
Rubel, J.R.1
Milford, E.L.2
McKay, D.B.3
Jarcho, J.A.4
-
34
-
-
33745393847
-
Tacrolimus with mycophenolate mofetil (MMF) or sirolimus vs. cyclosporine with MMF in cardiac transplant patients: 1-year report
-
Kobashigawa J.A., Miller L.W., Russell S.D., et al. Tacrolimus with mycophenolate mofetil (MMF) or sirolimus vs. cyclosporine with MMF in cardiac transplant patients: 1-year report. Am J Transplant 6 (2006) 1377-1386
-
(2006)
Am J Transplant
, vol.6
, pp. 1377-1386
-
-
Kobashigawa, J.A.1
Miller, L.W.2
Russell, S.D.3
-
35
-
-
33745288559
-
Wound healing complications with de novo sirolimus versus mycophenolate mofetil-based regimen in cardiac transplant recipients
-
Kuppahally S., Al-Khaldi A., Weisshaar D., et al. Wound healing complications with de novo sirolimus versus mycophenolate mofetil-based regimen in cardiac transplant recipients. Am J Transplant 6 (2006) 986-992
-
(2006)
Am J Transplant
, vol.6
, pp. 986-992
-
-
Kuppahally, S.1
Al-Khaldi, A.2
Weisshaar, D.3
-
36
-
-
18544381706
-
Clinical experience with everolimus (Certican): optimizing dose and tolerability
-
Pascual J., Marcén R., and Ortuño J. Clinical experience with everolimus (Certican): optimizing dose and tolerability. Transplantation 79 suppl (2005) S80-S84
-
(2005)
Transplantation
, vol.79
, Issue.SUPPL
-
-
Pascual, J.1
Marcén, R.2
Ortuño, J.3
-
37
-
-
29544448704
-
Evolution of proteinuria after conversion from calcineurin inhibitors (CNI) to sirolimus (SRL) in renal transplant patients: a multicenter study
-
Ruiz J.C., Diekmann F., Campistol J.M., et al. Evolution of proteinuria after conversion from calcineurin inhibitors (CNI) to sirolimus (SRL) in renal transplant patients: a multicenter study. Transplant Proc 37 (2005) 3833-3835
-
(2005)
Transplant Proc
, vol.37
, pp. 3833-3835
-
-
Ruiz, J.C.1
Diekmann, F.2
Campistol, J.M.3
-
38
-
-
33750008433
-
Increase of proteinuria after conversion from calcineurin inhibitor to sirolimus-based treatment in kidney transplant patients with chronic allograft dysfunction
-
Ruiz J.C., Campistol J.M., Sanchez-Fructuoso A., et al. Increase of proteinuria after conversion from calcineurin inhibitor to sirolimus-based treatment in kidney transplant patients with chronic allograft dysfunction. Nephrol Dial Transplant 21 (2006) 3252-3257
-
(2006)
Nephrol Dial Transplant
, vol.21
, pp. 3252-3257
-
-
Ruiz, J.C.1
Campistol, J.M.2
Sanchez-Fructuoso, A.3
-
39
-
-
7244245756
-
Predictors of success in conversion from calcineurin inhibitor to sirolimus in chronic allograft dysfunction
-
Diekmann F., Budde K., Oppenheimer F., et al. Predictors of success in conversion from calcineurin inhibitor to sirolimus in chronic allograft dysfunction. Am J Transplant 4 (2004) 1869-1875
-
(2004)
Am J Transplant
, vol.4
, pp. 1869-1875
-
-
Diekmann, F.1
Budde, K.2
Oppenheimer, F.3
-
40
-
-
35048832248
-
Elevated serum levels of vascular endothelial growth factor (VEGF) and proteinuria in renal allograft recipients treated with mTOR inhibitors
-
Stracke S., Mayer J.M., Henne-Bruns D., and Keller F. Elevated serum levels of vascular endothelial growth factor (VEGF) and proteinuria in renal allograft recipients treated with mTOR inhibitors. Transplantation 82 suppl 2 (2006) 299
-
(2006)
Transplantation
, vol.82
, Issue.SUPPL. 2
, pp. 299
-
-
Stracke, S.1
Mayer, J.M.2
Henne-Bruns, D.3
Keller, F.4
-
41
-
-
34547592986
-
Development of proteinuria after switch to sirolimus based immunosuppression in long-term cardiac transplant patients
-
Aliabadi A.Z., Kammerstätter D.P., Seebacher G., et al. Development of proteinuria after switch to sirolimus based immunosuppression in long-term cardiac transplant patients. Transplantation 82 suppl 2 (2006) 562
-
(2006)
Transplantation
, vol.82
, Issue.SUPPL. 2
, pp. 562
-
-
Aliabadi, A.Z.1
Kammerstätter, D.P.2
Seebacher, G.3
-
42
-
-
33644928466
-
Sirolimus-associated heavy proteinuria in a renal transplant recipient: evidence for a tubular mechanism
-
Straathof-Galema L., Wetzels J.F., Dijkman H.B., Steenbergen E.J., and Hilbrands L.B. Sirolimus-associated heavy proteinuria in a renal transplant recipient: evidence for a tubular mechanism. Am J Transplant 6 (2006) 429-433
-
(2006)
Am J Transplant
, vol.6
, pp. 429-433
-
-
Straathof-Galema, L.1
Wetzels, J.F.2
Dijkman, H.B.3
Steenbergen, E.J.4
Hilbrands, L.B.5
-
43
-
-
0037623516
-
Sirolimus therapy without calcineurin inhibitors: Necker Hospital 8-year experience
-
Morelon E., and Kreis H. Sirolimus therapy without calcineurin inhibitors: Necker Hospital 8-year experience. Transplant Proc 35 (2003) 52-57
-
(2003)
Transplant Proc
, vol.35
, pp. 52-57
-
-
Morelon, E.1
Kreis, H.2
-
44
-
-
33745767702
-
Long-term cardiovascular risk in transplantation-insights from the use of everolimus in heart transplantation
-
Eisen H. Long-term cardiovascular risk in transplantation-insights from the use of everolimus in heart transplantation. Nephrol Dial Transplant 21 suppl 3 (2006) iii9-iii13
-
(2006)
Nephrol Dial Transplant
, vol.21
, Issue.SUPPL. 3
-
-
Eisen, H.1
-
45
-
-
33750377251
-
The impact of proliferation signal inhibitors on the healthcare burden of major adverse cardiac events following heart transplantation
-
Eisen H., and Yang X. The impact of proliferation signal inhibitors on the healthcare burden of major adverse cardiac events following heart transplantation. Transplantation 82 (2006) 13-18
-
(2006)
Transplantation
, vol.82
, pp. 13-18
-
-
Eisen, H.1
Yang, X.2
-
46
-
-
20844455929
-
Immune and nonimmune predictors of cardiac allograft vasculopathy onset and severity: multivariate risk factor analysis and role of immunosuppression
-
Caforio A.L., Tona F., Fortina A.B., et al. Immune and nonimmune predictors of cardiac allograft vasculopathy onset and severity: multivariate risk factor analysis and role of immunosuppression. Am J Transplant 4 (2004) 962-970
-
(2004)
Am J Transplant
, vol.4
, pp. 962-970
-
-
Caforio, A.L.1
Tona, F.2
Fortina, A.B.3
-
47
-
-
27644436740
-
Maintenance immunosuppression with target-of-rapamycin inhibitors is associated with a reduced incidence of de novo malignancies
-
Kauffman H.M., Cherikh W.S., Cheng Y., et al. Maintenance immunosuppression with target-of-rapamycin inhibitors is associated with a reduced incidence of de novo malignancies. Transplantation 80 (2005) 883-889
-
(2005)
Transplantation
, vol.80
, pp. 883-889
-
-
Kauffman, H.M.1
Cherikh, W.S.2
Cheng, Y.3
-
48
-
-
20144367584
-
Sirolimus for Kaposi's sarcoma in renal-transplant recipients
-
Stallone G., Schena A., Infante B., et al. Sirolimus for Kaposi's sarcoma in renal-transplant recipients. N Engl J Med 352 (2005) 1317-1323
-
(2005)
N Engl J Med
, vol.352
, pp. 1317-1323
-
-
Stallone, G.1
Schena, A.2
Infante, B.3
-
49
-
-
33748189496
-
Sirolimus (SRL) in heart transplantation: preliminary results of a multicenter registry in Spain (Rapacor study)
-
Delgado J., Crespo M.G., Manito N., et al. Sirolimus (SRL) in heart transplantation: preliminary results of a multicenter registry in Spain (Rapacor study). Am J Transplant 5 suppl 11 (2005) S172
-
(2005)
Am J Transplant
, vol.5
, Issue.SUPPL. 11
-
-
Delgado, J.1
Crespo, M.G.2
Manito, N.3
-
50
-
-
0038300674
-
Use of rapamycin slows progression of cardiac transplant vasculopathy
-
Mancini D., Pinney S., Burkhoff D., et al. Use of rapamycin slows progression of cardiac transplant vasculopathy. Circulation 107 (2003) 48-53
-
(2003)
Circulation
, vol.107
, pp. 48-53
-
-
Mancini, D.1
Pinney, S.2
Burkhoff, D.3
-
51
-
-
4243198694
-
Rapastat: evaluation of the role of oral sirolimus in the treatment of established graft vessel disease. A prospective, randomized intravascular ultrasound study
-
Segovia J., Alonso-Pulpon L., Ortiz P., et al. Rapastat: evaluation of the role of oral sirolimus in the treatment of established graft vessel disease. A prospective, randomized intravascular ultrasound study. J Heart Lung Transplant 23 suppl 2 (2004) S51
-
(2004)
J Heart Lung Transplant
, vol.23
, Issue.SUPPL. 2
-
-
Segovia, J.1
Alonso-Pulpon, L.2
Ortiz, P.3
-
52
-
-
0037296071
-
Rapamycin as rescue therapy in a patient supported by biventricular assist device to heart transplantation with consecutive ongoing rejection
-
Ankersmit H.J., Roth G., Zuckermann A., et al. Rapamycin as rescue therapy in a patient supported by biventricular assist device to heart transplantation with consecutive ongoing rejection. Am J Transplant 3 (2003) 231-234
-
(2003)
Am J Transplant
, vol.3
, pp. 231-234
-
-
Ankersmit, H.J.1
Roth, G.2
Zuckermann, A.3
-
53
-
-
33645458234
-
Sirolimus therapy after early cyclosporine withdrawal reduces the risk of cancer in adult renal transplantation
-
Campistol J.M., Eris J., Oberbauer R., et al. Sirolimus therapy after early cyclosporine withdrawal reduces the risk of cancer in adult renal transplantation. J Am Soc Nephrol 17 (2006) 581-589
-
(2006)
J Am Soc Nephrol
, vol.17
, pp. 581-589
-
-
Campistol, J.M.1
Eris, J.2
Oberbauer, R.3
-
54
-
-
10044246181
-
Therapeutic drug monitoring for everolimus in heart transplant recipients based on exposure-effect modeling
-
Starling R.C., Hare J.M., Hauptman P., et al. Therapeutic drug monitoring for everolimus in heart transplant recipients based on exposure-effect modeling. Am J Transplant 4 (2004) 2126-2131
-
(2004)
Am J Transplant
, vol.4
, pp. 2126-2131
-
-
Starling, R.C.1
Hare, J.M.2
Hauptman, P.3
-
56
-
-
23944471153
-
Deep sternal wound infection after cardiac surgery: modality of treatment and outcome
-
Immer F.F., Durrer M., Mühlemann K.S., et al. Deep sternal wound infection after cardiac surgery: modality of treatment and outcome. Ann Thorac Surg 80 (2005) 957-961
-
(2005)
Ann Thorac Surg
, vol.80
, pp. 957-961
-
-
Immer, F.F.1
Durrer, M.2
Mühlemann, K.S.3
-
57
-
-
24944484995
-
Vacuum-assisted closure for sternal wounds: a first-line therapeutic management approach
-
Agarwal J.P., Ogilvie M., Wu L.C., et al. Vacuum-assisted closure for sternal wounds: a first-line therapeutic management approach. Plast Reconstr Surg 116 (2005) 1035-1040
-
(2005)
Plast Reconstr Surg
, vol.116
, pp. 1035-1040
-
-
Agarwal, J.P.1
Ogilvie, M.2
Wu, L.C.3
-
58
-
-
33645841612
-
Everolimus (Certican) in renal transplantation: a review of clinical trial data, current usage, and future directions
-
Pascual J., Boletis I.N., and Campistol J.M. Everolimus (Certican) in renal transplantation: a review of clinical trial data, current usage, and future directions. Transplant Rev 20 (2006) 1-18
-
(2006)
Transplant Rev
, vol.20
, pp. 1-18
-
-
Pascual, J.1
Boletis, I.N.2
Campistol, J.M.3
-
59
-
-
0029692603
-
Thoracoscopic creation of a pericardial window for recurrent pericardial effusion after heart transplantation
-
Brandt M., Brückner M., Hirt S.W., et al. Thoracoscopic creation of a pericardial window for recurrent pericardial effusion after heart transplantation. Eur J Cardio-thorac Surg 10 (1996) 220-222
-
(1996)
Eur J Cardio-thorac Surg
, vol.10
, pp. 220-222
-
-
Brandt, M.1
Brückner, M.2
Hirt, S.W.3
-
61
-
-
0034065402
-
Clinical pharmacokinetics and therapeutic drug monitoring of sirolimus
-
MacDonald A., Scarola J., Burke J.T., and Zimmerman J.J. Clinical pharmacokinetics and therapeutic drug monitoring of sirolimus. Clin Ther 22 suppl B (2000) B101-B121
-
(2000)
Clin Ther
, vol.22
, Issue.SUPPL. B
-
-
MacDonald, A.1
Scarola, J.2
Burke, J.T.3
Zimmerman, J.J.4
-
62
-
-
0033729567
-
Pharmacokinetics of SDZ RAD and cyclosporin including their metabolites in seven kidney graft patients after the first dose of SDZ RAD
-
Kirchner G.I., Winkler M., Mueller L., et al. Pharmacokinetics of SDZ RAD and cyclosporin including their metabolites in seven kidney graft patients after the first dose of SDZ RAD. Br J Clin Pharmacol 50 (2000) 449-454
-
(2000)
Br J Clin Pharmacol
, vol.50
, pp. 449-454
-
-
Kirchner, G.I.1
Winkler, M.2
Mueller, L.3
-
63
-
-
0030832514
-
SDZ RAD, a new rapamycin derivative: pharmacological properties in vitro and in vivo
-
Schuler W., Sedrani R., Cottens S., et al. SDZ RAD, a new rapamycin derivative: pharmacological properties in vitro and in vivo. Transplantation 64 (1997) 36-42
-
(1997)
Transplantation
, vol.64
, pp. 36-42
-
-
Schuler, W.1
Sedrani, R.2
Cottens, S.3
-
64
-
-
33745197501
-
Long-term safety and effectiveness of statins for heart transplant recipients in routine clinical practice
-
Grigioni F., Carigi S., Potena L., et al. Long-term safety and effectiveness of statins for heart transplant recipients in routine clinical practice. Transplant Proc 38 (2006) 1507-1510
-
(2006)
Transplant Proc
, vol.38
, pp. 1507-1510
-
-
Grigioni, F.1
Carigi, S.2
Potena, L.3
-
65
-
-
27844521938
-
Ten-year follow-up of a randomized trial of pravastatin in heart transplant patients
-
Kobashigawa J.A., Moriguchi J.D., Laks H., et al. Ten-year follow-up of a randomized trial of pravastatin in heart transplant patients. J Heart Lung Transplant 24 (2005) 1736-1740
-
(2005)
J Heart Lung Transplant
, vol.24
, pp. 1736-1740
-
-
Kobashigawa, J.A.1
Moriguchi, J.D.2
Laks, H.3
-
66
-
-
17844373853
-
Immunosuppressive therapy with everolimus can be associated with potentially life-threatening lingual angioedema
-
Fuchs U., Zittermann A., Berthold H.K., et al. Immunosuppressive therapy with everolimus can be associated with potentially life-threatening lingual angioedema. Transplantation 79 (2005) 981-983
-
(2005)
Transplantation
, vol.79
, pp. 981-983
-
-
Fuchs, U.1
Zittermann, A.2
Berthold, H.K.3
-
67
-
-
20344387487
-
Preservation of renal function after heart transplantation: initial single-center experience with sirolimus
-
De Meester J.M., Van Vlem B., Walravens M., et al. Preservation of renal function after heart transplantation: initial single-center experience with sirolimus. Transplant Proc 37 (2005) 1835-1838
-
(2005)
Transplant Proc
, vol.37
, pp. 1835-1838
-
-
De Meester, J.M.1
Van Vlem, B.2
Walravens, M.3
-
68
-
-
33745006874
-
Acne in recipients of renal transplantation treated with sirolimus: clinical, microbiologic, histologic, therapeutic, and pathogenic aspects
-
Mahe E., Morelon E., Lechaton S., et al. Acne in recipients of renal transplantation treated with sirolimus: clinical, microbiologic, histologic, therapeutic, and pathogenic aspects. J Am Acad Dermatol 55 (2006) 139-142
-
(2006)
J Am Acad Dermatol
, vol.55
, pp. 139-142
-
-
Mahe, E.1
Morelon, E.2
Lechaton, S.3
-
69
-
-
33646096245
-
Resolution of sirolimus-induced pneumonitis after conversion to everolimus
-
Rehm B., Keller F., Mayer J., and Stracke S. Resolution of sirolimus-induced pneumonitis after conversion to everolimus. Transplant Proc 38 (2006) 711-713
-
(2006)
Transplant Proc
, vol.38
, pp. 711-713
-
-
Rehm, B.1
Keller, F.2
Mayer, J.3
Stracke, S.4
-
71
-
-
33748129890
-
Sirolimus-associated interstitial pneumonitis in 3 heart transplant recipients
-
Delgado J.F., Torres J., Ruiz-Cano M.J., et al. Sirolimus-associated interstitial pneumonitis in 3 heart transplant recipients. J Heart Lung Transplant 25 (2006) 1171-1174
-
(2006)
J Heart Lung Transplant
, vol.25
, pp. 1171-1174
-
-
Delgado, J.F.1
Torres, J.2
Ruiz-Cano, M.J.3
-
72
-
-
0031708127
-
Comparison of PRA-STAT, sHLA-EIA, and anti-human globulin-panel reactive antibody to identify alloreactivity in pretransplantation sera of heart transplant recipients: correlation to rejection and posttransplantation coronary artery disease
-
Kerman R.H., Susskind B., Kerman D., et al. Comparison of PRA-STAT, sHLA-EIA, and anti-human globulin-panel reactive antibody to identify alloreactivity in pretransplantation sera of heart transplant recipients: correlation to rejection and posttransplantation coronary artery disease. J Heart Lung Transplant 17 (1998) 789-794
-
(1998)
J Heart Lung Transplant
, vol.17
, pp. 789-794
-
-
Kerman, R.H.1
Susskind, B.2
Kerman, D.3
|